InvestorPlace
With so much death and economic destruction wrought by the novel coronavirus, its hard to find the silver lining. But if there is one on Wall Street, its the rise of artificial intelligence stocks. Yes, there is the profitability angle from machine learning and other relevant technology facilitates. But this crisis has been a crash course in the sectors viability.Hopefully, we wont suffer a second wave like many European countries are experiencing because, you know, people can just get over themselves and wear a flipping mask in public. But even if we do succumb to a second round, eventually, this too shall pass. However, the return to some sense of normalcy will likely take time. Thus, we may depend on contactless platforms. Of course, this international emergency has provided an excellent arena for finetuning.As well, its becoming clear that the scale and acceleration of our globalized economy is more than human brains can handle. Yes, we are the ultimate innovative species (as far as I know). However, machines can now play a major role in alleviating most if not one day all of our menial tasks. That frees us up for greater and more meaningful innovations, which is the underlying ethos of artificial intelligence stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThis isnt just techno-babble gibberish. For instance, the food supply chain was put under enormous stress during the peak of Covid-19. Well before the pandemic, many retailers partnered with AI programmers to develop enhanced forecasting and planning infrastructure. Now, this need has accelerated due to the baptism of fire. Therefore, these diverse artificial intelligence stocks could enjoy upside throughout this year and beyond.Apple (NASDAQ:AAPL)Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL)IBM (NYSE:IBM)Nvidia (NASDAQ:NVDA)Tencent (OTCMKTS:TCEHY)Match Group (NASDAQ:MTCH)Trade Desk (NASDAQ:TTD)The 7 Top Robinhood Stocks for OctoberFinally, not everything about AI has to be so serious. Since were conducting our business and personal affairs increasingly online, almost anything that we can think of, including love and dating, can benefit from the integration of man and machine. Since this dynamic is well under way, here are the seven artificial intelligence stocks from which you can profit.Apple (AAPL)Source: View Apart / Shutterstock.comAs the manufacturer of the now-iconic iPhone, Apple is more well known as a consumer electronics behemoth rather than an investment into artificial intelligence stocks. Certainly, the company can bank simply on the power of its globally recognized brand. However, what makes AAPL stock special is that management refuses to be satisfied with its prior accomplishments.As evidence, consider Apples foray into electric vehicles. At one point, rumors circulated that hundreds of people were developing a car, one that could possibly compete with Tesla (NASDAQ:TSLA). Nowadays, it appears that the consumer tech firm is focusing on developing software for self-driving cars. If thats the case, such a course would require significant innovations in AI, particularly machine learning.Theoretically, Apple has a lot of practice in this arena thanks to its wealth of consumer data. In addition, the company has forged consumer friendly applications, such as palm rejection technology. This nifty development allows the iPad to recognize the difference between a deliberate input with the Apple Pencil versus accidental contact with a part of the hand.Undoubtedly, most investors will buy AAPL stock for its ever-popular smart devices. However, those who are interested in artificial intelligence stocks should also give it serious consideration.Alphabet (GOOG, GOOGL)Source: BigTunaOnline / Shutterstock.comWhenever anyone talks about artificial intelligence stocks, Alphabet is one of the top names thats mentioned and for good reason. Essentially, Alphabets Google owns the internet. As of July 2020, Google dominated desktop search engines with an 87% global market share. With figures like that, youre bound to have a wealth of consumer data that other organizations can only dream about.And with search dominance comes its web advertisement-driven revenue channels. Corporations spend billions buying up Google ads because thats where the people are. In turn, Alphabet has gotten quite adept at utilizing its AI infrastructure to fine-tune what consumers want and just as importantly, when they want it. Additionally, thanks to its YouTube platform, Alphabet has years of valuable experience understanding and predicting consumer behavior.Therefore, while GOOGL stock is often the target of social and political criticism, I dont see the internet giant going anywhere but up over a long-term horizon.7 Internet of Things Stocks for Investing in InnovationPlus, what really makes Alphabet stand out is its penchant for relevant acquisitions. For example, its DeepMind subsidiary specializes in traffic prediction algorithms. Thats not just important for everyday convenience but also as a framework for smart city infrastructures. Therefore, if you want more AI in your portfolio, go get some GOOGL stock.IBM (IBM)Source: JHVEPhoto / Shutterstock.comAlthough artificial intelligence stocks represent one of the hottest segments on Wall Street, individual names tend to be well-known entities. As such, theyre not exactly what you would call undervalued as they typically have already garnered much investor sentiment.Well, IBM doesnt have that problem. As a legacy tech giant, Big Blue has struggled over the years to shed its image of yesteryear innovations. Instead, management has pivoted to many relevant markets, including cloud computing and cybersecurity. However, IBM stock is frustrating, even in this year where its down 10% while other tech firms are up big.Nevertheless, if you want to go against the grain with your artificial intelligence stocks, IBM offers the patient investor potentially significant upside. As you know, with its AI platform Watson, Big Blue has been helping multiple enterprises and industries maximize their efficiency. One particular area that Im intrigued in is healthcare.With the novel coronavirus having disrupted this sector, theres never been a more critical time for improved efficiencies. Here, IBM could make a conspicuously positive impact, reducing administrative friction so that medical professionals can spend less time on paperwork and more time helping patients. Having learned tough lessons from the new normal, the pandemic could help IBM stock regain its footing.Nvidia (NVDA)Source: Hairem / Shutterstock.comWhen you hear the brand Nvidia, most likely what comes to mind first is video games. And thats not a bad thing, believe me. Before the pandemic, video games, especially the rise of eSports, helped drive the bullish case for NVDA stock. During the lockdowns and the new normal, this entertainment platform helped while away the hours when other options were off the table.Despite its dominance in gaming, Nvidia would like to let you know that its one of the leaders in artificial intelligence stocks as well. The companys partnership with Walmart (NYSE:WMT) illustrates this relationship perfectly. As a big-box retailer, Walmart must make critical decisions all the time about their inventory: how much to buy, when to ship them out and to which stores, among countless other concerns.Fortunately, Walmart has advanced data analytics software that references back decades of data for hundreds of millions of products. But all that data processing requires sophisticated hardware otherwise, youre not going anywhere. Thats where Nvidia comes in with its graphics processors. Sure, theyre best known for their gaming applications, but they can do so much more.The 7 Best Semiconductor Stocks to Buy TodayNot surprisingly, NVDA stock has significant links to other burgeoning industries, such as self-driving technologies and the blockchain. Therefore, youll want to keep this on your short list of artificial intelligence stocks to buy.Tencent (TCEHY)Source: StreetVJ / Shutterstock.comTaking aside the politics, if you want to broaden your portfolio of artificial intelligence stocks, you should look at China. Companies like Tencent really are in an enviable position. For one, Tencents home market has blossomed into a technological powerhouse. Second, Chinas massive population means ample room for growth, increased connectivity and the biggest data goldmine.Further, Tencent has wide-reaching ambitions regarding its AI initiatives. As an internet content and social media network provider, the company is finetuning personalized advertisements and suggestions for its millions of users. In addition, Tencent is pursuing more serious endeavors, such as medical AI applications. Here, the idea is to use technology to help physicians detect and prevent the spread of disease.With the coronavirus having originated from China as President Trump reminds us every day this application seems very relevant for TCEHY stock.Of course, nothing can be divorced from politics these days and so it is with Tencent. As the owner of WeChat, the messaging/payments app has come under fire from the Trump administration. And that might mean TCEHY stock is on shaky ground, at least until we figure out who will run our nation on Nov. 3. Still, the opportunity for upside is tantalizing because of the aforementioned attributes of the home market.Match Group (MTCH)Source: ShutterstockInvariably, analyses of artificial intelligence stocks typically involve high-scale solutions. Over this list, weve covered the impact that AI can have on our purchasing decisions, interactions with machines, forecasting inventory demand and improving health outcomes. But AI doesnt have to be so serious. Instead, it can help with that age-old longing for love.Thats right, for those of who want to give Cupid an assist, online dating apps, such as those under the Match Group umbrella, may help accelerate your search for a soulmate. But what if Cupid needs help too? Increasingly, the mythical god has turned to artificial intelligence to help provide appropriate matchups.In a way, this is the probably the most ingenious use of AI. By now, many of these dating sites and apps have collected an enormous amount of behavioral data. Thats also due to the stigma of online dating fading away. Plus, with the novel coronavirus disrupting offline dating, Match is one of the viable places to go. That right there is a great reason to consider MTCH stock.10 ESG Stocks to Buy for a Brighter FutureBetter yet, Match is wising up to the power of AI to promote a safe dating environment. The company invested in Noonlight to provide safety features such as location tracking in case a meetup goes awry. Thats smart thinking, which should separate MTCH stock from other social networking investments.Trade Desk (TTD)Source: BrightSpace / Shutterstock.comWell before the pandemic, the cord-cutting phenomenon was placing increased pressure on traditional cable TV providers. With the advent of connected TV and streaming services, these innovations sparked never-before-seen capabilities, such as on-demand viewing. Instead of people revolving their lives around content scheduling (as in linear TV), the new generation of entertainment adapted to the individual.Following the coronavirus impact, the pressure to cut the cord intensified for many households. This was especially true during the early days of the crisis, when new content offerings were thin but the bills kept piling up. But pandemic or not, streaming and connected TV is here to stay. And that makes Trade Desk a relevant idea among artificial intelligence stocks.Primarily, the company utilizes AI algorithms to maximize advertisers return for their connected TV dollars. Thats much easier now because Trade Desk has access to a wealth of viewership data. As a result, its able to pinpoint which advertising strategies will work best, bolstering the narrative for TTD stock.Further, with live sports returning, Trade Desk may have an opportunity to evangelize its services. Because of the added cord-cutting pressures, the live sports streaming audience has probably increased significantly. That plays into the hands of TTD stock, where the underlying company can help advertisers plan for the possibility of games that go into overtime, which will likely feature a substantial uptick in engaged viewers.On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare.More From InvestorPlaceWhy Everyone Is Investing in 5G All WRONGAmericas #1 Stock Picker Reveals His Next 1,000% WinnerRevolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 CompanyCould Tiny Super Battery Kill Big Tech?The post 7 Artificial Intelligence Stocks to Buy for October appeared first on InvestorPlace.
Continued here:
Innovative Gx Laboratories Announces the Grand Opening of Its Molecular Diagnostic Laboratory in Texas - Yahoo Finance
- Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer [Last Updated On: August 17th, 2024] [Originally Added On: May 3rd, 2010]
- A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs [Last Updated On: August 17th, 2024] [Originally Added On: August 2nd, 2010]
- Pharmacogenomics [Last Updated On: August 17th, 2024] [Originally Added On: October 10th, 2011]
- Drug Firms Want More Access to Genetic Specimens - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 14th, 2011]
- India joins genome club -Genomics in India - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 14th, 2011]
- Classic: Weinshilboum: Inherited Variations in Drug and Neurotransmitter Metabolism 1981 - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 14th, 2011]
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict... - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 24th, 2011]
- Antidepressant Use Increases Significantly - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 28th, 2011]
- Kelan G. Tantisira, MD, MPH - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 31st, 2011]
- Human Security Thesis, personalized medicine, pharmacogenomics, Pharmacogenomics - Introduction - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 8th, 2011]
- Pamela Sklar: 2011 Allen Institute for Brain Science Symposium - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 8th, 2011]
- Pharmacy Doctor Oct 2011 A #1.wmv - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 13th, 2011]
- R. Stephanie Huang, PhD: The Role of Pharmacogenomics and Anticancer Drugs - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 19th, 2011]
- Individualized Molecular Testing for Personalized Medicine - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 21st, 2011]
- Where Science Meets Faith: Anticipating the Future - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 28th, 2011]
- Pharmacogenomics of psychotropic drugs - Video [Last Updated On: August 17th, 2024] [Originally Added On: December 6th, 2011]
- 2008 IPIT Awards Seminar: Hans Hogerzeil - Video [Last Updated On: August 17th, 2024] [Originally Added On: December 7th, 2011]
- Asuragen CLIA Pharmacogenomic Services - Video [Last Updated On: August 17th, 2024] [Originally Added On: December 8th, 2011]
- Pilot Demonstration Projects Group 4: Pharmacogenomics - Alan Shuldiner - Video [Last Updated On: August 17th, 2024] [Originally Added On: December 16th, 2011]
- Pharmacogenomics - Howard McLeod - Video [Last Updated On: August 17th, 2024] [Originally Added On: December 17th, 2011]
- Clinical Implementation of Psychiatric Pharmacogenomics - David Mrazek - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 10th, 2012]
- PROMISE - Bionexus Partnership Launching montage - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 16th, 2012]
- Dr. William Figg: Handling Pharmacogenomic Information - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 19th, 2012]
- Using Payer Data to Analyze Impact of Pharmacogenomic Approaches - Robert Epstein - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 22nd, 2012]
- Dr. Russ Altman on Pharmacogenomics - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 26th, 2012]
- AssureRx Health Secures $8M Financing with Silicon Valley Bank to Support Growth [Last Updated On: August 17th, 2024] [Originally Added On: January 31st, 2012]
- BSc Biomedical Sciences courses at Brunel University - Video [Last Updated On: August 17th, 2024] [Originally Added On: February 1st, 2012]
- Companion Diagnostics Market to Explode as Personalized Medicine Market Catapults to $42 Billion by 2015 [Last Updated On: August 17th, 2024] [Originally Added On: February 3rd, 2012]
- Gaming Wins Big at National Science Foundation's Visualization Challenge [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2012]
- SBCE to organise international meet on Molecular Medicine [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- FDA Evaluating MolecularHealth's MASE for Analyzing Post-Market Drug Safety [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Genome BC Funds $9.8M Project to Identify Subgroups in Medulloblastoma for Personalized Treatment [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Future US Nucleic Acid Testing Market Outlook [Last Updated On: August 17th, 2024] [Originally Added On: February 16th, 2012]
- China Clears Its First Microarray Platform for in Vitro Diagnostics to Accelerate Personalized Medicine [Last Updated On: August 17th, 2024] [Originally Added On: February 16th, 2012]
- ACLA Says Cuts in Medicare Lab Payments Could Hurt Nascent Personalized Dx Segment [Last Updated On: August 17th, 2024] [Originally Added On: February 20th, 2012]
- OncTerm- Pharmacogenomics - Video [Last Updated On: August 17th, 2024] [Originally Added On: February 21st, 2012]
- A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer' [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- International meet on molecular medicine begins at SBCE [Last Updated On: August 17th, 2024] [Originally Added On: February 24th, 2012]
- Demonstrating Cost Effectiveness of Clinical NGS is Key to Payor Reimbursement, Hospital Uptake [Last Updated On: August 17th, 2024] [Originally Added On: February 24th, 2012]
- Darien High Schoolers fare well at science fair [Last Updated On: August 17th, 2024] [Originally Added On: February 27th, 2012]
- US Hematology & Flow Cytometry Market Future Discussed in New Report Published at MarketPublishers.com [Last Updated On: August 17th, 2024] [Originally Added On: February 29th, 2012]
- ACM Global Central Lab Launches Workshop Series to Share Expert Insights on Navigating Global Clinical Trials with a ... [Last Updated On: August 17th, 2024] [Originally Added On: February 29th, 2012]
- Fitch: Drug Makers Continue to Face Challenges at the Beginning of the Drug Channel [Last Updated On: August 17th, 2024] [Originally Added On: February 29th, 2012]
- Will PCORI's Patient-Centered Comparative Effectiveness Research Track with Personalized Rx? [Last Updated On: August 17th, 2024] [Originally Added On: March 3rd, 2012]
- Generex to Meet with FDA about AE37 HER2 Peptide Vaccine; Companion Dx Path Still Unclear [Last Updated On: August 17th, 2024] [Originally Added On: March 6th, 2012]
- Vermillion's OVA1 Test Assigned Category 1 CPT Code; Stock Jumps [Last Updated On: August 17th, 2024] [Originally Added On: March 7th, 2012]
- Transgenomic Reports Fiscal Year 2011 Financial Results [Last Updated On: August 17th, 2024] [Originally Added On: March 7th, 2012]
- Transgenomic's Q4 Revenues Increase 69 Percent [Last Updated On: August 17th, 2024] [Originally Added On: March 7th, 2012]
- Research and Markets: Molecular Diagnostics: Market Segmentation and Opportunities - Emphasis on NGS and Its Emerging ... [Last Updated On: August 17th, 2024] [Originally Added On: March 7th, 2012]
- AMA Approves Vermillion MAAA Category 1 Code for OVA1; Will it Improve Reimbursement? [Last Updated On: August 17th, 2024] [Originally Added On: March 7th, 2012]
- USPSTF Updating BRCA Testing Recommendations for Asymptomatic Women; Accepting Public Input [Last Updated On: August 17th, 2024] [Originally Added On: March 8th, 2012]
- Global Biochips Market to Reach US$4.6 Billion by 2017, According to New Report by Global Industry Analysts, Inc. [Last Updated On: August 17th, 2024] [Originally Added On: March 10th, 2012]
- WSU venturing into pharmacogenomics - Tue, 13 Mar 2012 PST [Last Updated On: August 17th, 2024] [Originally Added On: March 13th, 2012]
- Research and Markets: Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice (6th ... [Last Updated On: August 17th, 2024] [Originally Added On: March 14th, 2012]
- With MDx Usage and Costs on the Rise, UnitedHealthCare Urges Reimbursement Reform [Last Updated On: August 17th, 2024] [Originally Added On: March 14th, 2012]
- Bioinformatics Market Outlook to 2015 [Last Updated On: August 17th, 2024] [Originally Added On: March 15th, 2012]
- WSU recruits geneticists in new research venture [Last Updated On: August 17th, 2024] [Originally Added On: March 15th, 2012]
- Pharmacogenomics - Video [Last Updated On: August 17th, 2024] [Originally Added On: March 15th, 2012]
- Free Book Download - Psychiatric Pharmacogenomics - Video [Last Updated On: August 17th, 2024] [Originally Added On: March 16th, 2012]
- PanGenX Takes Semantic-based Approach to Data Integration, Analytics for Personalized Medicine [Last Updated On: August 17th, 2024] [Originally Added On: March 17th, 2012]
- Research and Markets: Bioinformatics Market Outlook to 2015 [Last Updated On: August 17th, 2024] [Originally Added On: March 21st, 2012]
- Quest Launches MDx that May Predict Kidney Transplant Rejection Earlier than Current Methods [Last Updated On: August 17th, 2024] [Originally Added On: March 21st, 2012]
- EMERGE Network Launches Publicly Available Database of Phenotype Identification Algorithms [Last Updated On: August 17th, 2024] [Originally Added On: March 23rd, 2012]
- Prospective Outcomes Trial Shows Agendia's MammaPrint Safely Reduces Chemo Use in Low-Risk Patients [Last Updated On: August 17th, 2024] [Originally Added On: March 26th, 2012]
- Abbott Challenges 'Incorrect Assumptions' in Cost-Effectiveness Study of Xalkori PGx Testing [Last Updated On: August 17th, 2024] [Originally Added On: March 26th, 2012]
- Genoptix Says NGS Melanoma Test Will Not Be Used to Place Patients in Trials for Parent Novartis [Last Updated On: August 17th, 2024] [Originally Added On: March 28th, 2012]
- St. Jude's Evans Receives Pharmacists Assn. Award [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- Perkins Chain Hires New CEO [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- PGx Highlights from American College of Cardiology Annual Meeting [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- Collecting Cancer Data [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- Study: Higher Plavix Dose Doesn't Improve Response for CYP2C19*2 Carriers; Effient May Be Best Option [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- UNC Analysis Finds Beta1-AR Alleles Impact Survival in Patients Treated with Beta-Blockers [Last Updated On: August 17th, 2024] [Originally Added On: March 29th, 2012]
- Q&A: GE Healthcare's Mark Dente on the Challenges of Integrating Genomics Data with EMRs [Last Updated On: August 17th, 2024] [Originally Added On: March 31st, 2012]
- Eastday-Neurosurgeon, geneticist take top prizes in science [Last Updated On: August 17th, 2024] [Originally Added On: March 31st, 2012]
- A New 'Omics Emerges [Last Updated On: August 17th, 2024] [Originally Added On: April 2nd, 2012]
- Up to the Task [Last Updated On: August 17th, 2024] [Originally Added On: April 2nd, 2012]
- NHGRI Plans to Fund More Clinical Sequencing Projects [Last Updated On: August 17th, 2024] [Originally Added On: April 7th, 2012]
- Doctor’s role is key to cancer fight [Last Updated On: August 17th, 2024] [Originally Added On: April 16th, 2012]
- People in the News: Josh LaBaer in as New President of US HUPO and More [Last Updated On: August 17th, 2024] [Originally Added On: April 22nd, 2012]
- Convey, CLC Bio to Provide Combined Software, Hardware NGS Data-Analysis Solution [Last Updated On: August 17th, 2024] [Originally Added On: April 22nd, 2012]